Published in J Travel Med on May 18, 2006
Cavitary pulmonary disease. Clin Microbiol Rev (2008) 2.31
Penicillium marneffei Infection in AIDS. Patholog Res Int (2011) 1.44
Penicillium marneffei infection in HIV-infected travelers. AIDS Alert (2006) 0.84
Acute Abdomen Due to Penicillium marneffei: An Indicator of HIV Infection in Manipur State. J Clin Diagn Res (2014) 0.75
Penicillium marneffei presenting as an immune reconstitution inflammatory syndrome (IRIS) in a patient with advanced HIV. BMJ Case Rep (2013) 0.75
Penicillium marneffei chylous ascites in acquired immune deficiency syndrome: a case report. World J Gastroenterol (2012) 0.75
Development and evaluation of a real-time polymerase chain reaction assay for the rapid detection of Talaromyces marneffei MP1 gene in human plasma. Mycoses (2016) 0.75
Uncommon opportunistic fungal infections of oral cavity: A review. J Oral Maxillofac Pathol (2014) 0.75
Prevention of Disseminated Penicillium marneffei in human immunodeficiency virus-infected Travelers. J Travel Med (2006) 0.75
A novel inhibition ELISA for the detection and monitoring of Penicillium marneffei antigen in human serum. Eur J Clin Microbiol Infect Dis (2016) 0.75
Relationship between HAART adherence and adipose tissue alterations. J Acquir Immune Defic Syndr (2002) 1.97
A third genotype of the human parvovirus PARV4 in sub-Saharan Africa. J Gen Virol (2008) 1.74
Human parvovirus 4 in the bone marrow of Italian patients with AIDS. AIDS (2007) 1.48
Resolution of multidrug-refractory oesophageal candidiasis in an AIDS patient after treatment with caspofungin. AIDS (2002) 1.37
Leishmaniasis among organ transplant recipients. Lancet Infect Dis (2008) 1.29
Body habitus changes and metabolic alterations in protease inhibitor-naive HIV-1-infected patients treated with two nucleoside reverse transcriptase inhibitors. J Acquir Immune Defic Syndr (2002) 1.27
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients. Autoimmun Rev (2011) 1.26
Thrombotic microangiopathy in patients with acquired immunodeficiency syndrome before and during the era of introduction of highly active antiretroviral therapy. Clin Infect Dis (2002) 1.17
Histoplasmosis among human immunodeficiency virus-infected people in Europe: report of 4 cases and review of the literature. Medicine (Baltimore) (2006) 1.15
Trends in the postmortem diagnosis of opportunistic invasive fungal infections in patients with AIDS: a retrospective study of 1,630 autopsies performed between 1984 and 2002. Am J Clin Pathol (2009) 1.03
Incidence of adipose tissue alterations in first-line antiretroviral therapy: the LipoICoNa Study. Arch Intern Med (2002) 1.03
Aspergillus meningitis: a rare clinical manifestation of central nervous system aspergillosis. Case report and review of 92 cases. J Infect (2012) 1.02
The role of cryptococcal antigen assay in diagnosis and monitoring of cryptococcal meningitis. J Clin Microbiol (2005) 1.01
Prospective observational study of fever in hospitalized returning travelers and migrants from tropical areas, 1997-2001. J Travel Med (2005) 1.00
Description of a "trans-Saharan" strain of human T-lymphotropic virus type 1 in West Africa. J Acquir Immune Defic Syndr (2008) 0.94
Intestinal lymphangiectasia and reversible high liver stiffness. Hepatology (2014) 0.89
Correlates of risk of adipose tissue alterations and their modifications over time in HIV-1-infected women treated with antiretroviral therapy. Antivir Ther (2003) 0.89
Acute parvovirus B19 infection and anemia during Plasmodium falciparum malaria. Clin Infect Dis (2002) 0.89
Liver-related factors associated with low vitamin D levels in HIV and HIV/HCV coinfected patients and comparison to general population. Curr HIV Res (2011) 0.88
Trends and predictors of non-AIDS-defining cancers in men and women with HIV infection: a single-institution retrospective study before and after the introduction of HAART. J Acquir Immune Defic Syndr (2013) 0.87
Is real-time polymerase chain reaction (PCR) more useful than a conventional PCR for the clinical management of leishmaniasis? Am J Trop Med Hyg (2009) 0.86
Human cytomegalovirus double resistance in a donor-positive/recipient-negative lung transplant patient with an impaired CD4-mediated specific immune response. J Antimicrob Chemother (2004) 0.85
Safety of statin therapy in HIV/hepatitis C virus-coinfected patients. J Acquir Immune Defic Syndr (2007) 0.85
ADAMTS 13 genotype and vWF protease activity in an Italian family with TTP. Thromb Haemost (2003) 0.85
Analysis of protease inhibitor combinations in vitro: activity of lopinavir, amprenavir and tipranavir against HIV type 1 wild-type and drug-resistant isolates. J Antimicrob Chemother (2004) 0.84
Paraurethral leiomyoma. Urology (2011) 0.82
Severe Plasmodium vivax malaria: fact or fiction? Clin Infect Dis (2012) 0.82
Thrombocytopenia and Plasmodium vivax malaria. Clin Infect Dis (2005) 0.81
Cholesterol levels in HIV-HCV infected patients treated with lopinavir/r: results from the SCOLTA project. Biomed Pharmacother (2007) 0.80
Usefulness of serial determination of Aspergillus galactomannan in the diagnosis and management of invasive aspergillosis in an AIDS patient with non-Hodgkin lymphoma. Mycoses (2011) 0.80
Chronic coinfection with hepatitis B and hepatitis C viruses in an Italian population of HIV-infected patients. J Acquir Immune Defic Syndr (2007) 0.79
Unusual codon 69 insertions: influence on human immunodeficiency virus type 1 reverse transcriptase drug susceptibility. J Clin Virol (2004) 0.78
Cytokine production in women with antiretroviral treatment-associated breast fat accumulation and limb wasting. AIDS (2003) 0.78
Gastrointestinal cancers reactive for the PAb416 antibody against JCV/SV40 T-Ag lack JCV DNA sequences while showing a distinctive pathologic profile. J Clin Pathol (2012) 0.78
Is switching protease inhibitor-based effective antiretroviral therapy safe in patients with AIDS-associated Kaposi's sarcoma? AIDS (2004) 0.77
Antibodies are forever: a study using 12-26-year-old expired antibodies. Histopathology (2013) 0.77
HAART simplification with lopinavir/ritonavir monotherapy in HIV/HCV co-infected patients starting anti-HCV treatment: a randomised pilot study (KaMon study). New Microbiol (2012) 0.77
Simplification of protease inhibitor-containing regimens with efavirenz, nevirapine or abacavir: safety and efficacy outcomes. Antivir Ther (2003) 0.76
KSHV reactivation in post-transplant Kaposi sarcoma. Nat Med (2003) 0.75
Maintenance of breast size reduction after mastoplasty and switch to a protease inhibitor-sparing regimen in an HIV-positive woman with highly active antiretroviral therapy-associated massive breast enlargement. AIDS Patient Care STDS (2002) 0.75
Pneumocystis carinii pneumonia after the discontinuation of long-term antiretroviral therapy in an HIV-1-infected pregnant woman. AIDS (2003) 0.75
Surgery and topic cidofovir for nasal squamous papillomatosis in HIV+ patient. Eur Arch Otorhinolaryngol (2008) 0.75
Comment on: Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients. J Antimicrob Chemother (2017) 0.75
Sarcoidosis presenting with massive involvement of the nervous system. Ann Intern Med (2005) 0.75
Itraconazole can be effective in the treatment of sporotrichoid leishmaniasis. J Travel Med (2004) 0.75
Human herpesvirus 8+ polyclonal IgMλ B-cell lymphocytosis mimicking plasmablastic leukemia/lymphoma in HIV-infected patients. Eur J Haematol (2013) 0.75
Accumulation of drug-related mutations in HIV-1 genome and virus replicative capacity in multi-drug failure subjects. J Antimicrob Chemother (2002) 0.75
Fungal endocarditis observed over an 8-year period and a review of the literature. Mycopathologia (2014) 0.75
Immunovirological outcomes in 70 HIV-1-infected patients who switched to lopinavir/ritonavir after failing at least one protease inhibitor-containing regimen: a retrospective cohort study. J Antimicrob Chemother (2003) 0.75
Long-term efficacy of the surgical treatment of buffalo hump in patients continuing antiretroviral therapy. AIDS (2004) 0.75
Retreatment of chronic hepatitis C virus infection after unsuccessful therapy with all-oral direct-acting antiviral regimens: a real-life experience. Eur J Gastroenterol Hepatol (2017) 0.75